Dalvance 500 MG vials
Ended Awarded
- Contract number
- SPE2DX25F6UFN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $3,647
Award facts
- Contract value 100% obligated
- $3,647.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 2, 2025, for the supply of Dalvance 500 mg vials with a contract ceiling value of $3,647.09. This is a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and was funded through the Defense Logistics Agency's Medical Supply Chain. The award was made through competitive procurement with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide.
Dalvance (dalbavancin) is an injectable antibiotic used to treat acute bacterial skin and skin structure infections. As a child contract under the DLA's broader pharmaceutical prime vendor program, this delivery order reflects AmerisourceBergen's established role as a critical vendor for federal military and veteran healthcare procurement. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements through open competition, serving multiple government healthcare entities including the Defense Health Agency and U.S. Coast Guard across various therapeutic domains.
Quick answers
Who was awarded contract SPE2DX25F6UFN?
SPE2DX25F6UFN was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 2, 2025.
How much is contract SPE2DX25F6UFN worth?
The government has obligated $3,647 on SPE2DX25F6UFN.
Is contract SPE2DX25F6UFN an order under another contract?
Yes. SPE2DX25F6UFN is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6UFN competed?
The extent of competition for SPE2DX25F6UFN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award